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Effect of Laparoscopic-assisted Gastropexy on Gastrointestinal
Transit Time in Dogs
I.M. Balsa, W.T.N. Culp , K.J. Drobatz, E.G. Johnson, P.D. Mayhew, and S.L. Marks
Background: Prophylactic gastropexy has been promoted as a means of preventing gastric volvulus during gastric dilata-
tion and volvulus (GDV) syndrome. Little is known about the impact of gastropexy on gastrointestinal transit time.
Hypothesis: Laparoscopic-assisted gastropexy (LAG) will not alter gastrointestinal transit times when comparing gastric
(GET), small and large bowel (SLBTT), and whole gut transit times (TTT) before and after surgery.
Animals: 10 healthy client-owned large-breed dogs.
Methods: Prospective clinical trial. Before surgery, all dogs underwent physical examination and diagnostic evaluation to
ensure normal health status. Dogs were fed a prescription diet for 6 weeks before determination of gastrointestinal transit
with a wireless motility capsule. LAG was then performed, and dogs were fed the diet for 6 additional weeks. Measurement
of transit times was repeated 6 weeks after surgery.
Results: Ten dogs of various breeds at-risk for GDV were enrolled. No complications were encountered associated with
surgery or capsule administration. There were no significant differences in GET 429 [306–1,370] versus 541 [326–1,298]
(P = 0.80), SLBTT 1,243 [841–3,070] versus 1,540 [756–2,623] (P = 0.72), or TTT 1,971 [1,205–3,469] versus 1,792 [1,234–
3,343] minutes (median, range) (P = 0.65) before and after LAG.
Conclusions and Clinical Importance: An effect of LAG on gastrointestinal transit time was not identified, and wireless
motility capsule can be safely administered in dogs after LAG.
Key words: Emptying; Endoscopy; Minimally invasive; Prophylactic.
Gastric dilatation and volvulus (GDV) is a life-threatening syndrome that occurs when the stom-
ach rotates, causing entrapment of gas, fluid, and food.1
This syndrome is most commonly seen in large- and
giant-breed deep-chested dogs such as great Danes,
Irish Wolfhounds, and standard poodles, although
GDV can affect any breed of dog.2
Prophylactic gastropexy is highly protective against
gastric volvulus,3 and there is interest in performing
prophylactic gastropexies in dogs that are at risk of
developing GDV. Prophylactic gastropexies are gener-
ally performed by traditional open techniques when
combined with other intraabdominal procedures, or by
minimally invasive techniques such as the grid
approach, endoscopically assisted, laparoscopic-assisted,
or laparoscopic approaches.4–7
A relatively new technique for assessing gastrointesti-
nal transit utilizing a wireless motility capsulea has been
developed which involves the ingestion of a
26 9 13 mm wireless transmitting capsule that sends
signals to a portable receiver worn by the dog.8,9 The
stored signals can then be assessed by display software
specifically designed for the capsule. The wireless motil-
ity capsule transmits data about pH, pressure, and tem-
perature to the receiver that can be retrieved and
analyzed. The alterations in temperature and pH are
used to determine the anatomic location of the capsule
within the gastrointestinal tract.
Despite the widespread acceptance of prophylactic
gastropexies, very little information is available about
the impact that this procedure has on gastrointestinal
motility. Of concern are rare case studies of dogs devel-
oping clinical signs of vomiting and delayed gastric
emptying times after prophylactic gastropexy.10 The
implementation of minimally invasive gastropexy tech-
niques makes the performance of prophylactic gas-
tropexies ever more attractive, likely increasing the
regularity with which these procedures are performed.
An understanding of the impact of prophylactic gas-
tropexy on gastric emptying and intestinal transit in
apparently healthy dogs is important to determine the
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role gastropexies have on the development of clinical
signs after surgery.
The aim of this study was to assess gastrointestinal
transit with wireless motility capsules in a cohort of
healthy dogs before and after prophylactic laparo-
scopic-assisted gastropexy (LAG). The null hypothesis
was that the performance of a LAG will not alter gas-
trointestinal transit when comparing gastric emptying
time (GET), small and large bowel transit time
(SLBTT), and total transit time (TTT) before and after
surgery.
Materials and Methods
Dogs
Client-owned giant- or large-breed dogs were enrolled in the
study, by a “before and after” design. The study protocol was
explained to the owner, and informed consent was obtained before
enrollment. The study was approved by the Institutional Animal
Care and Use Committee. A thorough history was obtained, and a
physical examination was performed on all enrolled dogs. A body
condition score (BCS) was determined, and only dogs with BCS of
4–6 (scale 1–9) were included. Dogs were not enrolled if they were
currently receiving any medications (excluding antiparasiticides) or
had a history of gastrointestinal disease.
The following laboratory and imaging procedures were per-
formed on all dogs before enrollment: complete blood count,
serum biochemical profile, urinalysis, serum cobalamin/folate con-
centration, serum trypsinogen-like immunoreactivity assay, fecal
centrifugation floatation, baseline serum cortisol concentration,
abdominal survey radiographs, and abdominal ultrasound. To be
included, dogs had to have no abnormalities in the above diagnos-
tics. Additionally, all dogs were dewormed with fenbendazole
(50 mg/kg PO q24 hours for 3 consecutive days). Owners were
responsible for keeping a daily diary of exercise activity, appetite,
and fecal score to note any abnormalities associated with the
intestinal diet or wireless motility capsule.
Diet
Once enrolled, all dogs were fed a standardized highly digestible
intestinal dietb for a period of 6 weeks. The diet was fed to meet
each dog’s daily metabolic energy requirement (MER). Resting
energy requirement was determined by the following equation:
resting energy requirement (RER) = 70 9 BW0.75 kcal/kg, and
MER was calculated by multiplying the RER by 1.6 (neutered
adult) or 1.8 (intact adult). Body weight and body condition score
were reassessed every 3 weeks throughout the study to determine
if any alteration to food intake was needed. Owners were also pro-
vided with hydrolyzed treatsc to aid in compliance with excluding
other foods during the study period.
Wireless Motility Capsule Administration
After 6 weeks of the dogs being fed the standardized diet, the
wireless motility capsule was administered PO after food was with-
held overnight for 12 hours, and all dogs received the capsule
between 09:00 and 12:00 hours. A test meal comprising 1/3rd of
the dog’s MER using the same standardized diet was fed to all
dogs before the capsule was administered PO. The dogs were given
the opportunity to drink 100 mL of water after which they were
fitted with a vest containing the data receiver. The owners then
took their dogs home to rapidly re-establish a normal stress-free
environment and were instructed to withhold food and water until
the pH had a persistent increase of at least 3 units above baseline
gastric pH (pH < 3.0 in all dogs) to correspond with movement of
the wireless motility capsule from the stomach into the duodenum.
A diary of events was provided to the owner so that specific infor-
mation about the dog’s activity level, defecation episodes and
times, passage of the capsule in the feces, as well as any potential
adverse effects could be articulated. Adverse effects included vomit-
ing, diarrhea, altered food intake, or altered activity (i.e. running
and playing). Activity was monitored by owners who assessed the
time period that the dogs spent walking, running, or playing on a
weekly basis. No gastric acid suppressants or other medications
were administered during the wireless motility capsule-monitoring
period.
After passage of the wireless motility capsule, a LAG was per-
formed as described below. After surgery, the standardized intesti-
nal diet was continued to be fed for an additional 6 weeks, at
which point, a second wireless motility capsule was administered.
Information obtained from the wireless motility capsule receivers
including gastrointestinal transit, pH, pressure, and temperature
were assessed and compared. MotiliGI version 2.2 softwared was
used to analyze the data and calculate the following GI transit
times: GET, SLBTT, and TTT.
LAG Procedure
All dogs were placed under general anesthesia utilizing a proto-
col as determined by the clinical anesthesiology service. The dogs
were placed in dorsal recumbency, and the ventral abdominal
region was clipped, prepared with aseptic technique, and draped.
The laparoscopic-assisted incisional gastropexy was performed as
described by Rawlings et al.11 A 1-cm incision was made on the
ventral midline 2-cm caudal to the umbilicus, and access to the
abdominal cavity was obtained by the modified Hasson
technique.5 A 6 mm cannula-trocar assemblye was inserted in this
location, and insufflation with CO2
f was commenced to an intraab-
dominal pressure of 9–12 mmHg. A 5-mm laparoscopeg was
inserted into the abdomen and aimed toward the right ventral
aspect of the abdomen. A 10-mm instrument cannulae was placed
through the right ventrolateral body wall (lateral to the rectus
abdominis muscle), ~3-cm caudal to the last rib. Endoscopic Bab-
cock forcepsh were passed through the instrument port, and the
stomach was grasped and pulled toward the body wall. The port
was removed from the body wall, and the gastric antrum was exte-
riorized. The abdominal incision of the instrument port was
increased to 4 cm in length, and stay sutures were placed at the
ends of the proposed gastric incision (4-cm apart). A 4-cm incision
was made through the seromuscular layer of the stomach. The
incised edges of the stomach were sutured to the incised edges of
the transversus abdominis muscle with 2 lines of 2-0 polydiox-
anone in simple continuous patterns. The final gastric positioning
was directly visualized after gastropexy. The abdominal oblique
muscles were closed with a simple continuous pattern with 3-0
polydioxanone. The subcutaneous tissues were apposed in a simple
continuous pattern with 3-0 polydioxanone. The dermal layer was
apposed using a subcuticular pattern with 3-0 poliglecaprone. The
midline incision was closed in the following manner: The linea
alba layer of the midline incision was closed with simple inter-
rupted sutures of 3-0 polydioxanone, and the dermal layer was
apposed using a subcuticular pattern with 3-0 poliglecaprone. All
dogs were discharged 1 day postoperatively, and tramadol (3 mg/
kg PO q8 hours) was administered for pain control for 3 days.
Statistical Analysis
An a priori power analysis was not performed. All continu-
ous variables were statistically conservatively considered to be
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not normally distributed and are described using median (min,
max). The Wilcoxon signed rank test was used to compare gas-
trointestinal transit times for each of the gastrointestinal seg-
ments assessed (GET, SLBTT, and TTT) before and after LAG.
A P-value of <0.05 was considered significant for all compar-
isons. All statistical analyses were performed by a statistical
software program.i
Results
Fifteen dogs were enrolled in the study. Five dogs
were removed from the study for the following reasons:
gastrointestinal foreign material on multiple abdominal
ultrasound examinations (n = 3), splenic hemangiosar-
coma (n = 1), lost to follow-up after the first wireless
motility capsule administration (n = 1). All included
dogs were determined to have laboratory test results
within the laboratory reference range. All dogs were
giant-to-large breeds and were considered deep-chested.
The breeds included were great Dane (n = 3), German
shepherd (2), standard poodle (2), Doberman pinscher
(1), Irish wolfhound (1), and a mixed breed (1). Six
dogs were intact males, 2 were intact females, 1 was a
spayed female, and 1 was a castrated male. The median
age was 18 months (range, 5–48 months), and the med-
ian weight was 39.8 kg (range, 21.2–68.5 kg). Six dogs
had a BCS of 4/9, 2 dogs had a BCS of 5/9, and 2 dogs
had a BCS of 6/9.
All wireless motility capsule administrations were suc-
cessful, and no complications were encountered with
capsule administration or LAG. During laparoscopic
evaluation, the stomach was noted to be in an appropri-
ate gastropexy position in all cases. Additionally, all
surgical incisions healed appropriately and no incisional
complications were noted. No alteration in fecal quality
or exercise activity (except for a prescribed decrease for
14 days postoperatively) was recorded in any dog, and
no dogs had clinical signs such as vomiting, regurgita-
tion, or changes in appetite.
The median (range) GET, SLBTT, and TTT were
429 (306–1,370), 1,243 (841–3,070), and 1,971 (1,205–
3,469) minutes, respectively, before surgery. The median
(range) GET, SLBTT, and TTT were 541 (326–1,298),
1,540 (756–2,623), and 1,792 (1,234–3,343) minutes,
respectively, after surgery. The median (range) differ-
ence in GET, SLBTT, and TTT when comparing before
and after LAG was 23 (587 to 583), 78 (447 to
571), and 26 (831 to 474) minutes, respectively
(Figs 1–3). There was no significant difference in GET
(P = 0.80), SLBTT (P = 0.72), or TTT (P = 0.65) after
LAG.
Discussion
The performance of a gastropexy is considered stan-
dard-of-care in dogs that have had GDV. Further, the
use of prophylactic gastropexy is being advocated as a
means of reducing the incidence of GDV in dogs predis-
posed to developing the disorder. While many clinicians
recommend the procedure in high-risk breeds, there is
little evidence describing the long-term functional out-
come of the gastrointestinal tract in those dogs with a
gastropexy. This study did not demonstrate that dogs
undergoing LAG have a change in GET, SLBTT, and
TTT after the LAG procedure.
The main historical options for the assessment of gut
transit include scintigraphy as the criterion-referenced
standard, radiopaque markers, and liquid barium upper
gastrointestinal studies. With the scintigraphic method,
patients ingest a meal containing a radioisotope and are
then imaged with a gamma camera.12 The gastrointesti-
nal emptying is assessed by repeating the imaging over
several hours being sure to note when the radioisotope
has left the stomach and entered the cecum. If colonic
transit is to be assessed as part of the study, images are
acquired 24–72 hours after ingestion of the radioiso-
tope. In 1 study comparing gastric emptying of a
Fig. 1. Plot of individual dog gastric emptying time (GET) before and after laparoscopic-assisted gastropexy for 10 dogs.
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radionuclide-labeled test meal after gastropexy in clini-
cally normal and GDV-affected dogs, there was no sig-
nificant difference in the gastric emptying rates and
pattern.13 Although scintigraphy has historically been
considered the gold standard in assessing gastrointesti-
nal transit time, studies have shown wireless motility
capsule and scintigraphy have similar variation and
repeatability in dogs.14
Radiopaque markers (ROMs) can also be utilized to
assess gastrointestinal motility and emptying. These
nondigestible markers are ingested within a gelatin cap-
sule which opens and releases the ROMs upon contact
with gastric juices.15,16 Serial radiographs are obtained
to evaluate the location of the markers within the gas-
trointestinal tract. The use of ROMs was evaluated in
both clinically normal dogs and dogs with GDV in 1
study.17 In that study, the performance of a circum-
costal gastropexy did not alter the 90% gastric empty-
ing time of the particles in healthy dogs; however, the
gastric emptying time in dogs with GDV that had
undergone circumcostal gastropexy was significantly
increased.17
Several disadvantages of the scintigraphic assessment
and ROMs have been identified. Scintigraphic assess-
ment requires expensive equipment, and there is an
exposure to radioactivity. Additionally, the scintigraphic
studies are long in duration requiring an extended per-
iod of time that clinicians and technical staff are dedi-
cated to a particular case.8 Furthermore, ROMs do not
technically measure gastric emptying of an actual meal
Fig. 2. Plot of individual dog small and large bowel transit time (SLBTT) before and after laparoscopic-assisted gastropexy for 10 dogs.
Fig. 3. Plot of individual dog total transit time (TTT) before and after laparoscopic-assisted gastropexy for 10 dogs.
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as these are not passed until food has left the stomach.
Instead they are utilized to measure gastric emptying of
the ROMs (nonphysiologic assessment). Lastly, these
techniques only offer the ability to assess emptying
(generally of only 1 segment of the gastrointestinal
tract) and do not provide additional information about
gastrointestinal pH, pressure, and temperature.
There are several advantages of the wireless motility
capsule used in this study. This system allows for the
assessment of motility within the entire gastrointestinal
tract, whereas other tests focus mainly on 1 particular
section of the gastrointestinal tract. The dogs are able
to remain in their normal environment and continue
their normal activity. Additionally, this system does not
require multiple tests or a serial exposure to radiation.
The wireless motility capsule utilized in this study is
accurate for measurement of gastrointestinal transit in
dogs and has been validated in several studies.14,18,19
All dogs in this study were safely administered a
wireless motility capsule, and no complications were
encountered. The smallest dog in this study weighed
approximately 21 kg; the use of wireless motility cap-
sules in small dogs was not assessed in this study. The
minimum weights of dogs in other studies receiving the
same wireless motility capsule used in this study were
similar (19–23 kg).18–20 Investigation of the use of the
capsule in smaller dogs would be useful, although not
likely pertinent when referring to prophylactic gas-
tropexy procedures, as GDV is uncommon in this
cohort of dogs. As has been shown in previous
studies,5,6 the LAG procedure was performed success-
fully with no complications. Additionally, utilizing the
described laparoscopic technique allowed the surgeons
to directly evaluate the gastropexy site with the laparo-
scope before completion of the procedure. This visual-
ization permitted confirmation of a successful and
appropriately positioned gastropexy.
Limitations of this study should be recognized. The
study included a small number of healthy dogs,
although, the use of a “before and after” study design
allowed each dog to serve as its own control. Regard-
less, a type II error is possible when utilizing a small
sample size, and it should be considered that the lack
of significance noted between before and after LAG
values could be due to this error. Additionally, as the
time frame for evaluation was short, this study lacks
long-term follow-up in these dogs to ensure that no
complications related to gastrointestinal motility
occurred. Further, this study only evaluated 1 specific
surgical technique performed or overseen by a board
certified surgeon in a variety of dogs, and differences
might be expected when utilizing different surgical
techniques or evaluating different breeds. Lastly, this
study did not evaluate the impact of this procedure on
transit times in dogs with underlying disease processes,
and extrapolation of results to this setting cannot be
performed.
This study supports the use of prophylactic gas-
tropexy in dogs at-risk for developing GDV as there
was no detected change in gastrointestinal transit as
assessed by wireless motility capsule. Additional
investigation of the use of wireless motility capsules to
assess dogs with gastrointestinal motility disturbances
after GDV is possible as this technology appears to be
safe in dogs with a gastropexy.
Footnotes
a SmartPill GI Monitoring System, Medtronic, Minneapolis, MN
b Purina Pro Plan Gastroenteric EN, Nestle Purina PetCare
Company, St. Louis, MO
c Purina Pro Plan Gentle Snackers, Nestle Purina PetCare
Company, St. Louis, MO
d SmartPill Corporation, Buffalo, NY
e Ternamian Endotip cannula, Karl Storz Veterinary Endoscopy,
Goleta, CA
f Endoflator, Karl Storz Veterinary Endoscopy, Goleta, CA
g Hopkins II, Karl Storz Veterinary Endoscopy, Goleta, CA
h Babcock Grasping Forceps, Karl Storz Veterinary Endoscopy,
Goleta, CA
i Stata 14.0 for Mac, Stata Corporation, College Station, TX
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